Inari Medical, Inc.’s (NASDAQ:NARI) Quiet Period Set To End on July 1st

Share on StockTwits

Inari Medical’s (NASDAQ:NARI) quiet period will end on Wednesday, July 1st. Inari Medical had issued 8,202,565 shares in its public offering on May 22nd. The total size of the offering was $155,848,735 based on an initial share price of $19.00. During Inari Medical’s quiet period, insiders and any underwriters involved in the IPO are restricted from issuing any earnings forecasts or research reports for the company because of SEC regulations. Following the end of the company’s quiet period, the brokerages that served as underwriters will likely initiate research coverage on the company.

A number of equities research analysts have weighed in on NARI shares. Bank of America started coverage on shares of Inari Medical in a research note on Tuesday, June 16th. They set a “neutral” rating and a $56.00 price target on the stock. Wells Fargo & Co started coverage on shares of Inari Medical in a research note on Tuesday, June 16th. They set an “equal weight” rating and a $49.00 price target on the stock. Canaccord Genuity assumed coverage on shares of Inari Medical in a research note on Friday, June 19th. They set a “buy” rating and a $60.00 price target on the stock. Finally, Morgan Stanley assumed coverage on Inari Medical in a report on Tuesday, June 16th. They set an “equal weight” rating and a $52.00 price objective for the company.

Shares of NASDAQ NARI opened at $48.02 on Wednesday. Inari Medical has a 52-week low of $39.55 and a 52-week high of $54.86.

In other Inari Medical news, major shareholder Presidio Management Group X. Ll purchased 97,962 shares of the business’s stock in a transaction that occurred on Wednesday, May 27th. The stock was acquired at an average cost of $19.00 per share, with a total value of $1,861,278.00. Also, CEO William Hoffman purchased 13,095 shares of the business’s stock in a transaction that occurred on Wednesday, May 27th. The stock was acquired at an average cost of $19.00 per share, with a total value of $248,805.00. Over the last three months, insiders have acquired 153,898 shares of company stock valued at $2,924,062.

Inari Medical Company Profile

There is no company description available for Inari Medical Inc

Further Reading: How does a dividend reinvestment plan work?

Receive News & Ratings for Inari Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Inari Medical and related companies with MarketBeat.com's FREE daily email newsletter.